Aims: To investigate the prognostic significance of hypoxia- and ferroptosis-related genes for gastric cancer (GC). Materials & methods: We extracted data on 259 hypoxia- and ferroptosis-related genes from The Cancer Genome Atlas and identified the differentially expressed genes between normal (n = 32) and tumor (n = 375) tissues. A risk score was established by univariate Cox regression analysis and LASSO penalized Cox regression analysis. Results: The risk score contained eight genes showed good performance in predicting overall survival and relapse-free survival in GC patients in both the training cohort (The Cancer Genome Atlas, n = 350) and the testing cohorts (GSE84437, n = 431; GSE62254, n = 300; GSE15459, n = 191; GSE26253, n = 432). Conclusion: The eight-gene signature may help to the improve the prognostic risk classification of GC.

Keywords:

Papers of special note have been highlighted as: •• of considerable interest

References

1. Thrift AP, El-Serag HB. Burden of gastric cancer. Clin. Gastroenterol. Hepatol. 18(3), 534–542 (2020). •• Proposed the challenges that human beings need to face in conquering gastric cancer.
MedlineGoogle Scholar
2. Patel TH, Cecchini M. Targeted therapies in advanced gastric cancer. Curr. Treat. Options Oncol. 21(9), 1–14 (2020). •• Summarized the the latest progress of treatment strategies for gastric cancer.
MedlineGoogle Scholar
3. Eusebi LH, Telese A, Marasco G, Bazzoli F, Zagari RM Gastric cancer prevention strategies: a global perspective. J. Gastroenterol. Hepatol. 35, 1495–1502 (2020).
MedlineGoogle Scholar
4. Sa JK, Hong JY, Lee I-K et al. Comprehensive pharmacogenomic characterization of gastric cancer. Genome Med. 12(1), 1–12 (2020).
Google Scholar
5. Sexton RE, Al Hallak MN, Diab M, Azmi ASJC, Reviews M. Gastric cancer: a comprehensive review of current and future treatment strategies. 39(4), 1179–1203 (2020).
Google Scholar
6. Dixon SJ, Lemberg KM, Lamprecht MR et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5), 1060–1072 (2012).
Medline CASGoogle Scholar
7. Stockwell BR, Angeli JPF, Bayir H et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171(2), 273–285 (2017).
Medline CASGoogle Scholar
8. Xie Y, Hou W, Song X et al. Ferroptosis: process and function. Cell Death Differ. 23(3), 369–379 (2016).
Medline CASGoogle Scholar
9. Silva VL. Exploiting the cancer niche: tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy. J. Control. Release 253, 82–96 (2017).
Medline CASGoogle Scholar
10. Huang Y, Lin D, Taniguchi CM. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe? Sci. China Life Sci. 60(10), 1114–1124 (2017).
Medline CASGoogle Scholar
11. Stoeltzing O, McCarty MF, Wey JS et al. Role of hypoxia-inducible factor 1α in gastric cancer cell growth, angiogenesis, and vessel maturation. J. Natl Cancer Inst. 96(12), 946–956 (2004).
Medline CASGoogle Scholar
12. Danza K, Silvestris N, Simone G et al. Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance. Cancer Biol. Ther. 17(4), 400–406 (2016).
Medline CASGoogle Scholar
13. Shi W-J, Gao J-B. Molecular mechanisms of chemoresistance in gastric cancer. World J. Gastrointest. Oncol. 8(9), 673 (2016).
MedlineGoogle Scholar
14. Verma HK, Falco G, Bhaskar L. Molecular signaling pathways involved in gastric cancer chemoresistance. In: Theranostics Approaches to Gastric and Colon Cancer. Springer, 117–134 (2020).
Google Scholar
15. Sinha A, Huang V, Livingstone J et al. The proteogenomic landscape of curable prostate cancer. Cancer Cell 35(3), 414–427.e416 (2019).
Medline CASGoogle Scholar
16. Bailey ST, Smith AM, Kardos J et al. MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma. Nat. Commun. 8(1), 1–12 (2017).
Medline CASGoogle Scholar
17. Huo J, Wu L, Zang Y. Development and validation of a novel immune–gene pairs prognostic model associated with CTNNB1 alteration in hepatocellular carcinoma. Med. Sci. Monit. 26, e925494–e925494 (2020).
Medline CASGoogle Scholar
18. Huo J, Wu L, Zang Y. A robust nine-gene prognostic signature associated with tumour doubling time for hepatocellular carcinoma. Life Sci. 260, 118396–118396 (2020).
Medline CASGoogle Scholar
19. Charoentong P, Finotello F, Angelova M et al. Pan-cancer immunogenomic analyses reveal genotype–immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 18(1), 248–262 (2017).
Medline CASGoogle Scholar
20. Newman AM, Liu CL, Green MR et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12(5), 453–457 (2015).
Medline CASGoogle Scholar
21. Serra O, Galán M, Ginesta M, Calvo M, Sala N, Salazar R. Comparison and applicability of molecular classifications for gastric cancer. Cancer Treat Rev. 77, 29–34 (2019).
Medline CASGoogle Scholar
22. Sano T, Coit DG, Kim HH et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer 20(2), 217–225 (2017).
MedlineGoogle Scholar
23. Godet I, Shin YJ, Ju JA, Ye IC, Wang G, Gilkes DM. Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis. Nat. Commun. 10(1), 1–18 (2019).
Medline CASGoogle Scholar
24. Yoshihara K, Shahmoradgoli M, Martínez E et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4(1), 1–11 (2013). •• Described how to estimate tumor purity by analyzing the specific gene expression characteristics of immune and stromal cells.
CASGoogle Scholar
25. Bezdenezhnykh N, Semesiuk N, Lykhova O, Zhylchuk V, Kudryavets Y. Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells. Exp. Oncol. 36, 72–78 (2014).
Medline CASGoogle Scholar
26. Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. In: Cancer Systems Biology. Springer, 243–259 (2018). •• Described how to quantify immune cell infiltration in tumor tissues with standardized gene presentation data.
Google Scholar
27. Zhang J, Piao H-Y, Guo S et al. LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12. 25(4), 1–14 (2020).
Google Scholar
28. Teng F, Xu Z, Chen J et al. DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer. Oncol. Rep. 40(3), 1203–1222 (2018).
Medline CASGoogle Scholar
29. Gong W, Qie S, Huang P, Xi J. Deletion of long noncoding RNA EFNA3 aggravates hypoxia-induced injury in PC-12 cells by upregulation of miR-101a. J. Cell Biochem. 120(1), 836–847 (2019).
Medline CASGoogle Scholar
30. Ren K, Liu Q, An Z, Zhang D, Chen X. MiR-144 functions as tumor suppressor by targeting PIM1 in gastric cancer. Eur. Rev. Med. Pharmacol. Sci. 21(13), 3028 (2017).
Medline CASGoogle Scholar
31. Wang Y, Qi Z, Zhou M et al. Stanniocalcin-1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl-2. Oncol. Rep. 41(3), 1998–2008 (2019).
Medline CASGoogle Scholar
32. Moore MJ, Blachere NE, Fak JJ et al. ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity. Elife 7, e33057 (2018).
MedlineGoogle Scholar
33. Xu B, Bai Z, Yin J, Zhang Z. Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer. PeerJ 7, e7091 (2019).
MedlineGoogle Scholar

Vol. 13, No. 11

Supplemental Materials

Metrics

Downloaded 662 times

History

Received 9 November 2020

Accepted 21 April 2021

Published online 4 May 2021

Published in print June 2021

Information

Keywords

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/epi-2020-0411

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing assistance was utilized in the production of this manuscript, which was personally funded by the authors.

Data availability statement

The datasets analyzed for this study were obtained from The Cancer Genome Atlas (TCGA) (https://portal.gdc.cancer.gov/), Gene Expression Omnibus (GEO) (https://www.ncbi.nlm.nih.gov/geo/) and MSigDB (http://www.broadinstitute.org/gsea/msigdb).

PDF download